Abstract
The chemokine stromal cell-derived factor-1 (SDF-1) and its receptor CXCR-4 contribute to stem cell homing and may play a role in the trafficking of leukemic cells. Therefore, we analyzed migration across Transwell filters of cells derived from bone marrow (BM) or peripheral blood (PB) from 26 acute myeloid leukemia (AML) patients. The presence of the extracellular matrix protein fibronectin (FN) strongly enhanced the spontaneous and SDF-1-induced migration of leukemic PB and BM cells. No differences in spontaneous, SDF-1-induced migration or CXCR-4 expression were observed between the different AML subtypes. Subsequently, it was determined whether SDF-1 preferentially promoted migration of subsets of leukemic cells. Leukemic cells expressing CD34, CD38 and HLA-DR were preferentially migrating, whereas cells expressing CD14 and CD36 showed diminished migration. Analysis of paired PB and BM samples indicated that significantly higher SDF-1-induced migration was observed in AML for CD34+ BM-derived cells compared to CD34+ PB-derived cells, suggesting a role for SDF-1 in the anchoring of leukemic cells in the BM or other organs. The lower percentage of circulating leukemic blasts in patients with a relatively high level of SDF-1-induced migration also supports this hypothesis. In conclusion, we have shown that primary AML cells are migrating towards SDF-1 independent of the AML subtypes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA . A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1) J Exp Med 1996 184: 1101–1109
Aiuti A, Webb IJ, Bleul C, Springer TA, Gutierrez-Ramos JC . The chemokine SDF-1 is a chemoattractant for human CD34+ hematopoietic progenitor cells and provides a new mechanism to explain the mobilization of CD34+ progenitors to peripheral blood J Exp Med 1997 185: 111–120
Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, Springer TA . The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV entry Nature 1996 382: 829–833
Oberlin E, Amara A, Bachelerie F, Bessia C, Virelizier J-L, Arenzana-Seisdedos F, Schwartz O, Heard J-M, Clark-Lewis I, Legler DF, Loetscher M, Baggiolini M, Moser B . The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line adapted HIV-1 Nature 1996 382: 833–835
Loetscher M, Geiser T, O'Reilly T, Zwahlen R, Baggiolini M, Moser B . Cloning of a human seven-transmembrane domain receptor LESTR, that is highly expressed in leukocytes J Biol Chem 1994 269: 232–237
Deichmann M, Kronenwett R, Haas R . Expression of the human immunodeficiency virus type-1 coreceptors CXCR-4 (fusin, LESTR) and CKR-5 in CD34+ hematopoietic progenitor cells Blood 1997 89: 3522–3528
Möhle R, Bautz F, Rafii S, Moore MAS, Brugger W, Kanz L . The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1 Blood 1998 91: 4523–4530
Voermans C, Gerritsen WR, von dem Borne AEG Kr, van der Schoot CE . Increased migration of cord blood-derived CD34+ cells, as compared to bone marrow and mobilized peripheral blood CD34+ cells across uncoated or fibronectin-coated filters Exp Hem 1999 27: 1806–1814
Kim CH, Broxmeyer HE . In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment Blood 1998 91: 100–110
Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, Yoshida N, Kikutani H, Kishimoto T . Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1 Nature 1996 382: 635–638
Ma Q, Jones D, Borghesani PR, Segal RA, Nagasawa T, Kishimoto T, Bronson RT, Springer TA . Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR-4- and SDF-1-deficient mice Proc Natl Acad Sci USA 1998 95: 9448–9453
Zou Y-R, Kottmann AH, Kudora M, Taniuchi I, Littman DR . Function of the chemokine receptor CXCR-4 in haematopoiesis and in cerebellar development Nature 1998 393: 595–599
Peled A, Petit I, Kollet O, Magid M, Ponomaryov T, Byk T, Nagler A, Ben-Hur H, Many A, Shultz L, Lider O, Alon R, Zipori D, Lapidot T . Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR-4 Science 1999 283: 845–848
Voermans C, Kooi MLK, Rodenhuis S, van der Lelie J, van der Schoot CE, Gerritsen WR . In vitro migratory capacity of CD34+ cells is related to hematopoietic recovery after autologous stem cell transplantation Blood 2001 97: 799–804
Möhle R, Failenschmid C, Bautz F, Kanz L . Overexpression of the chemokine receptor CXCR4 in B cells chronic lymphocytic leukemia is associated with increased functional response to stromal cell-derived factor-1 (SDF-1) Leukemia 1999 13: 1954–1959
Dürig J, Rosenthal C, Elmaagacli A, Heyworth C, Halfmeyer K, Kasper C, Novotny J, Dührsen U . Biological effects of stromal-derived factor-1α on normal and CML CD34+ haemopoietic cells Leukemia 2000 14: 1652–1660
Bradstock KF, Makrynikola V, Bianci A, Shen W, Hewson J, Gottlieb DJ . Effects of the chemokine stromal cell-derived factor-1 on the migration and localization of precursor-B acute lymphoblastic leukemia cells within bone marrow stromal layers Leukemia 2000 14: 882–888
Löwenberg B, Downing JR, Burnett A . Acute myeloid leukemia N Engl J Med 1999 341: 1051–1062
Kluin-Nelemans J, Van Wering E, Van Der Schoot C, Adriaansen H, Van'T Veer M, Van Dongen J, Gratama J Dutch Co-operative Study Group on Immunophenotyping of Haematological Malignancies (SIHON). SIHONSCORE: a scoring system for external quality control of leukaemia/lymphoma immunophenotyping measuring all analytical phases of laboratory performance Br J Haematol 2001 112: 337–343
Francis K, Ramakrishna R, Holloway W, Palsson BO . Two new pseudopod morphologies displayed by the human hematopoietic KG1a progenitor cell line and by primary human CD34(+) cells Blood 1998 92: 3616–3623
Dedhar S . Integrins and signal transduction Curr Opin Hematol 1999 6: 37–43
Clark EA, Brugge JS . Integrins and signal transduction pathways: the road taken Science 1995 268: 233–239
Liesveld JL, Dispersio JF, Abboud CN . Integrins and adhesive receptors in normal and leukemic CD34+ progenitor cells: potential regulatory checkpoints for cellular traffic Leuk Lymphoma 1994 14: 19–28
Bendall LJ, Kortlepel K, Gottlieb DJ . Human acute myeloid leukemia cells bind to bone marrow stroma via a combination of beta-1 and beta-2 integrin mechanisms Blood 1993 82: 3125–3132
Weimar IS, Voermans C, Bourhis J-H, Miranda N, van den Berk PCM, Nakamura T, de Gast GC, Gerritsen WR . Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells Leukemia 1998 12: 1195–1203
Pelletier AJ, van Der Laan LJ, Hildbrand P, Siani MA, Thompson DA, Dawson PE, Torbett BE, Salomon DR . Presentation of chemokine SDF-1α by fibronectin mediates directed migration of T cells Blood 2000 96: 2682–2690
Möhle R, Schittenhelm M, Failenschmid C, Bautz F, Kratz-Albers K, Serve H, Brugger W, Kanz L . Functional response of leukemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR-4 in acute myelomonocytic and lymphoblastic leukemia Br J Haematol 2000 110: 563–572
Acknowledgements
The authors are grateful to Colette van den Bogaard from the HIT lab and all hematologists and specialists for internal diseases from the Netherlands Cancer Institute, Amsterdam for collecting bone marrow and peripheral blood samples of AML patients. We also thank Dr van ‘t Veer of the Hovon Review Committee for MDS and AML. Furthermore, we acknowledge the specialists for internal diseases of the Free University, Onze Lieve Vrouwe Gasthuis and Slotervaart Hospital Amsterdam, Spittaal Hospital Zutphen, Lucas Hospital Apeldoorn, RKZ Heemskerk, Zeeweg Hospital IJmuiden, Gelderse Vallei Bennekom, SFG Rotterdam, Bronovo Hospital Den Haag, Mesos Medical Center, Utrecht and the Rijnstate Hospital Arnhem, for their cooperation with this project. We thank Dr Dirk Roos for critically reading the manuscript.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Voermans, C., van Heese, W., de Jong, I. et al. Migratory behavior of leukemic cells from acute myeloid leukemia patients. Leukemia 16, 650–657 (2002). https://doi.org/10.1038/sj.leu.2402431
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2402431
Keywords
This article is cited by
-
Current methods for studying metastatic potential of tumor cells
Cancer Cell International (2022)
-
Leukemia stem cell-bone marrow microenvironment interplay in acute myeloid leukemia development
Experimental Hematology & Oncology (2021)
-
Leukaemia: a model metastatic disease
Nature Reviews Cancer (2021)
-
LINC00665 promotes the progression of acute myeloid leukemia by regulating the miR-4458/DOCK1 pathway
Scientific Reports (2021)
-
The FLT3-ITD mutation and the expression of its downstream signaling intermediates STAT5 and Pim-1 are positively correlated with CXCR4 expression in patients with acute myeloid leukemia
Scientific Reports (2019)